Novartis Pharmaceuticals to Face Possible False Claims Act Liability for Kickbacks

Swiss-based Novartis Pharmaceuticals has been subjected to possible liability under the False Claims Act – and a federal judge in New York recently concluded the case may continue. In U.S. ex rel. Bilotti v. Novartis Pharmaceuticals Corp., a whistleblower brought to light several issues involving the drug maker, most notably its business model involving [...]

By | 2018-09-14T14:05:15+00:00 October 8th, 2014|Healthcare Fraud|